NEW YORK, June 15 (Reuters) – A Manhattan hedge fund manager
was charged on Wednesday with trading on confidential tips about
drug approvals, in one of the biggest insider trading cases
since a 2014…
The post CORRECTED-UPDATE 3-Visium’s Valvani charged with insider trading on FDA leaks appeared first on NASDAQ.